COMPANY DOCTOR
SC 13G, 1997-02-28
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: PIONEER INDIA FUND, 485BPOS, 1997-02-28
Next: GABELLI GLOBAL MULTIMEDIA TRUST INC, NSAR-B, 1997-02-28



<PAGE>   1
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                  SCHEDULE 13G


                   UNDER THE SECURITIES EXCHANGE ACT OF 1934

                          (AMENDMENT NO. __________)*


                               THE COMPANY DOCTOR
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                                  COMMON STOCK
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                  203908 10 9
                ---------------------------------------------
                                 (CUSIP Number)


*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).





                              Page 1 of 5 pages
<PAGE>   2
CUSIP NO. 203908 10 9               13G                     PAGE 2  OF  5  PAGES
           ------------                                         ---    ---      



    1      NAME OF REPORTING PERSON
           S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                            DONALD F. ANGLE, M.D.


    2      CHECK THE APPROPRIATE BOX IF A MEMBER OF GROUP*
                                                                     (a) [ ]
                                                                     (b) [ ]
                                                                          

    3      SEC USE ONLY




    4      CITIZENSHIP OR PLACE OF ORGANIZATION

                            UNITED STATES

                            5     SOLE VOTING POWER
         NUMBER                           1,259,884
        OF SHARES
      BENEFICIALLY          6     SHARED VOTING POWER
        OWNED BY                          1,259,884
          EACH
        REPORTING           7     SOLE DISPOSITIVE POWER
       PERSON WITH                        1,259,884

                            8     SHARED DISPOSITIVE POWER
                                          1,259,884

    9      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                            1,259,884

    10     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*




    11     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

                            25.3%

    12     TYPE OF REPORTING PERSON*

                            IN





                              Page 2 of 5 pages
<PAGE>   3
                                 SCHEDULE 13G

ITEM   1.

   (a) Name of Issuer:

       THE COMPANY DOCTOR

   (b) Address of Issuer's Principal Executive Offices:

       5215 N. O'CONNOR BOULEVARD, SUITE 1800
       IRVING, TEXAS  75039

ITEM   2.

   (a) Name of Persons Filing:

       DONALD F. ANGLE, M.D.

   (b) Address of Principal Business Office or, if none, Residence:

       5215 N. O'CONNOR BOULEVARD, SUITE 1800
       IRVING, TEXAS  75039

   (c) Citizenship:

       UNITED STATES

   (d) Title of Class of Securities:

       COMMON STOCK

   (e) CUSIP Number:

       203908 10 9

ITEM   3.  IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B),
           CHECK WHETHER THE PERSONS FILING ARE A:

   (a) [ ] Broker or Dealer registered under section 15 of the Act

   (b) [ ] Bank as defined in section 3(a)(6) of the Act

   (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act

   (d) [ ] Investment Company registered under section 8 of the Investment
           Company Act

   (e) [ ] Investment Adviser registered under section 203 of the Investment
           Advisers Act of 1940

   (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
           provisions of the Employee Retirement Income Security Act of 1974
           or Endowment Fund

   (g) [ ] Parent Holding Company, in accordance with
           Section 240.13d-1(b)(ii)(G)

   (h) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)





                              Page 3 of 5 Pages
<PAGE>   4
ITEM   4.  OWNERSHIP

   (a) Amount Beneficially Owned:

       1,259,884 shares

   (b) Percent of Class:

       25.3%

   (c) Number of shares as to which such persons (See Item 6 below) have:

          i) sole power to vote or to direct the vote: 1,259,884 shares

         ii) shared power to vote or to direct the vote: 1,259,884 shares

        iii) sole power to dispose or to direct the disposition of: 1,259,884
               shares

         iv) shared power to dispose or to direct the disposition of: 1,259,884
               shares

ITEM   5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

   If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].

ITEM   6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

       Not applicable.

ITEM   7.   IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
            THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

       Not applicable.

ITEM   8.  IDENTIFICATION AND CLASSIFICATION OF MEMBER OF THE GROUP

       Not applicable.

ITEM   9.  NOTICE OF DISSOLUTION OF GROUP

       Not applicable.

ITEM   10.  CERTIFICATION

       Not applicable.





                              Page 4 of 5 Pages
<PAGE>   5
                                   SIGNATURE

   After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


                                            FEBRUARY 13, 1997               
                                            ------------------              
                                            Date                            
                                                                            
                                                                            
                                                /s/  Donald F. Angle, M.D.  
                                            ------------------------------  
                                            DONALD F. ANGLE, M.D.           
                                   
                                   






                              Page 5 of 5 Pages


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission